Table 2.

Detailed descriptive results on plasma levels of the selected inflammatory molecules for all measurement points.

pg/ml or ng/ml^	Mean	SD	Median	Minimum	Maximum	75th perc	25th perc
CCL2 baseline	131.5	32.1	127.4	66.7	203.3	110.0	139.8
CCL2 8 Gy	136.8	37.7	134.6	60.5	200.4	111.9	171.4
CCL2 50 Gy	146.6	41.8	145.8	57.7	217.1	118.6	167.1
CCL2 end RT	157.3	34.5	158.4	102.6	240.8	131.2	174.1
CCL2 1 mos	167.9	79.7	143.2	74.6	461.7	127.5	187.2
IL-1b baseline	0.0	0.0	0.0	0.0	0.2	0.0	0.0
IL-1b 8 Gy	0.0	0.1	0.0	0.0	0.5	0.0	0.0
IL-1b 50 Gy	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL-1b end RT	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL-1b 1 mos	0.0	0.0	0.0	0.0	0.2	0.0	0.0
IL-6 baseline	1.6	1.2	1.6	0.0	3.5	0.3	2.5
IL-6 8 Gy	1.4	1.3	2.1	0.0	3.2	0.2	2.3
IL-6 50 Gy	1.6	1.4	1.6	0.0	4.7	0.2	2.3
IL-6 end RT	1.6	1.1	1.8	0.0	3.2	1.3	2.3
IL-6 1 mos	1.7	1.2	2.2	0.0	3.9	0.5	2.5
CXCL8 baseline	5.7	2.0	5.2	3.7	10.4	4.3	5.9
CXCL8 8 Gy	5.5	2.4	4.6	3.4	12.5	3.9	6.4
CXCL8 50 Gy	5.7	2.0	5.1	3.7	11.4	4.4	6.2
CXCL8 end RT	6.3	2.7	5.4	2.9	13.4	4.6	7.7
CXCL8 1 mos	8.3	9.1	5.7	4.1	46.1	4.7	7.2
PTX3 baseline	3.3	1.1	3.0	1.8	5.6	2.3	4.3
PTX3 8 Gy	3.9	1.2	3.9	1.9	6.3	3.1	4.6
PTX3 50 Gy	3.3	1.1	3.3	1.6	5.6	2.5	4.0
PTX3 end RT	3.5	1.3	3.7	1.4	6.3	2.6	4.1
PTX3 1 mos	3.1	1.1	3.1	1.1	5.1	2.0	4.0
TNF alpha baseline	3.1	2.5	3.9	0.0	7.4	0.4	4.9
TNF alpha 8 Gy	2.7	2.3	2.9	0.0	6.5	0.4	4.9
TNF alpha 50 Gy	2.8	2.6	2.7	0.0	9.2	0.2	4.6
TNF alpha end RT	2.7	2.2	2.8	0.0	6.1	0.2	4.5
TNF alpha 1 mos	3.1	2.2	3.6	0.0	7.0	1.2	4.3

^pg/ml for IL-1b, IL-6, CXCL8, CCL2, and TNF alpha; ng/ml: PTX3; SD: standard deviation; perc: percentile; 1 mos: 1 month; RT: radiotherapy.